ORUDIS

This brand name is authorized in Australia, Finland, Italy, South Africa, Spain.

Active ingredients

The drug ORUDIS contains one active pharmaceutical ingredient (API):

1	Ketoprofen UNII 90Y4QC304K - KETOPROFEN
	Ketoprofen is a non-steroidal anti-inflammatory drug. It has anti-inflammatory and analgesic actions.
	Read more about Ketoprofen

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
ORUDIS SR Capsule	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
M01AE03	Ketoprofen	M Musculo-skeletal system → M01 Antiinflammatory and antirheumatic products → M01A Antiinflammatory and antirheumatic products, non-steroids → M01AE Propionic acid derivatives
Discover more medicines within M01AE03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	1590Q, 5136H
ES	Centro de información online de medicamentos de la AEMPS	52097, 55857, 57128
FI	Lääkealan turvallisuus- ja kehittämiskeskus	018476, 459404, 479142
IT	Agenzia del Farmaco	023183027, 023183193, 023183205
ZA	Health Products Regulatory Authority	F/3.1/76